Literature DB >> 4729730

Hematoporphyrin-derivative-fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia, and carcinoma in situ of the cervix uteri.

G A Kyriazis, H Balin, R L Lipson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729730     DOI: 10.1016/0002-9378(73)90041-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  7 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Haematoporphyrin diacetate: a probe to distinguish malignant from normal tissue by selective fluorescence.

Authors:  R W Henderson; G S Christie; P S Clezy; J Lineham
Journal:  Br J Exp Pathol       Date:  1980-08

3.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

4.  Haematoporphyrins in the diagnosis and treatment of carcinoma of the bladder.

Authors:  J F Kelly
Journal:  Proc R Soc Med       Date:  1975-08

5.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

6.  Photodynamic destruction of human bladder carcinoma.

Authors:  J F Kelly; M E Snell; M C Berenbaum
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

7.  In vitro studies on the potential use of 5-aminolaevulinic acid-mediated photodynamic therapy for gynaecological tumours.

Authors:  F M Rossi; D L Campbell; R H Pottier; J C Kennedy; E F Dickson
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.